key: cord-0967488-s05lt8ca authors: Yazdanpanah, Niloufar; Rezaei, Nima title: Autoimmune complications of COVID‐19 date: 2021-08-31 journal: J Med Virol DOI: 10.1002/jmv.27292 sha: 1da933b6eeff6b9739d2bb88a755a9dfd78cb9bd doc_id: 967488 cord_uid: s05lt8ca Coronavirus disease 2019 (COVID‐19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID‐19 disease period, there is an accumulating body of evidence concerning the late‐onset complications of COVID‐19, of which autoimmune manifestations have attracted remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain‐Barre syndrome, and the detection of autoantibodies are the cues to the discovery of the potential of COVID‐19 in inducing autoimmunity. Clarification of the pathophysiology of COVID‐19 injuries to the host, whether it is direct viral injury or autoimmunity, could help to develop appropriate treatment. The world has witnessed the emergence of the rapidly growing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since December 2019. Affecting almost all countries, areas, and territories with more than 195 million confirmed cases and over 4 million death worldwide at the time of this writing-July 26, 2021, 1 this newly emerged virus has become the main health concern since late 2019. 2 Different mechanisms are hypothesized to explain how infections might provoke autoimmune reactions. Epitope spreading, bystander activation, cross-reaction or molecular mimicry, and presentation of cryptic antigens are the suggested mechanisms. 13 For instance, type 1 diabetes mellitus (T1DM) as one of the most prevalent autoimmune diseases has been suggested to be associated with coxsackievirus, 14 cytomegalovirus (CMV), 15 and enteroviruses. 16 Different types of viral infections such as hepatitis C virus (HCV), 17 CMV, 18 dengue virus, 19 and parvovirus B19 20, 21 have been postulated to be associated with systemic lupus erythematosus (SLE) that represent a wide variety of autoimmune manifestations. Furthermore, multiple sclerosis (MS) has been found to be associated with Epstein-Barr virus (EBV), 22 measles virus, 23 Varicella-zoster virus, 24 and CMV 25, 26 ( Table 1) . The aforementioned examples support the role of viral infections in the initiation of autoimmune diseases particularly in individuals with genetic susceptibility. Considering the current challenges of the COVID-19 pandemic regarding the discovery of proper vaccine or treatment, mental and physical health complications of social isolation, and healthcare expenses, the huge burden of this pandemic is evident. 45 On the other hand, autoimmune diseases induce a noticeable burden to society, individuals, and the healthcare system as well, as these are prevalent chronic conditions with no definite treatment up to date. 46 infection. Taking into consideration that viruses can induce type II and IV hypersensitivity reactions besides their specific cytopathic effect, COVID-19-mediated autoimmunity might be rationalized. 48 Production of autoantibodies following a viral infection that potentially leads to tissue injury (cross-reaction) is the suggested mechanism for viral-induced autoimmunity based on the concept of type II hypersensitivity. 49 Regarding type IV hypersensitivity, it is suggested that activated T cells against the virus might damage the selftissues by conducting an inflammatory environment or directly attacking the cells. Furthermore, there are many theories explaining how SARS-CoV-2 mediates a hyperinflammatory state that results in autoimmune reactions; for instance, vascular injury due to immune- T cells were influenced more significantly than others were. CD3 + CD4 + T helper cells were reduced as well as the CD3 + CD8 + suppressor T cells, whereas CD3 + CD8 + CD28 + suppressor cells were much remarkably lower in severe cases but the decrease in CD4 + CD8 + HLA-DR + suppressor T cells level was not reported to be more significant in severe cases than in non-severe patients. 52 Furthermore, naïve T cells and induced T regulatory They observed that incidence of thyroiditis during the convalescence period was rare; however, imbalances in the thyroid function tests and the detection of anti-thyroid antibodies in these patients highlighted the importance of thyroid screening tests in patients who have a history of COVID-19. 86 Nevertheless, patients who had detectably altered thyroid function at admission recovered through the convalescence period. 86 An overview of the recent reports regarding the autoimmune complications of COVID-19 is provided in Table 2 . T A B L E 2 Reports of the most prevalent autoimmune conditions associated with COVID-19 137 Hence, a more precise understanding of the involved mechanisms potentially helps to monitor and prevent the incidence or exacerbation of autoimmune manifestations. The authors declare that there are no conflict of interests. China Case series 28 Chen et al. 133 SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19 Autoimmune and inflammatory diseases following COVID-19 COVID-19 infection associated with autoimmune hemolytic anemia Cutaneous autoimmune diseases during COVID-19 pandemic Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids The role of infections in autoimmune disease Coxsackievirus and type 1 diabetes mellitus: the Wolf's footprints Association of cytomegalovirus infection with autoimmune type 1 diabetes Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Simultaneous presentation of parvovirus b19 infection and systemic lupus erythematosus in a patient: description and review of the literature The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging The MSMV hypothesis: measles virus and multiple sclerosis, etiology and treatment Varicella-zoster virus at relapses of multiple sclerosis Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: a systematic review and meta-analysis Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? Enterovirus in the chronic fatigue syndrome Electron microscopic immunocytological profiles in chronic fatigue syndrome Detection of RNA sequences in cultures of a stealth virus isolated from the cerebrospinal fluid of a health care worker with chronic fatigue syndrome Autoimmune hepatitis following Epstein-Barr virus infection Extrahepatic immune related manifestations in chronic hepatitis C virus infection West Nile virus infection with hearing loss Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis Cytomegalovirus as a driver of excess cardiovascular mortality in rheumatoid arthritis: a red herring or a smoking gun? Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms Guillain-Barré syndrome: epidemiology, pathophysiology and management Guillain-Barré syndrome Viral infections associated with Kawasaki disease Disease and healthcare burden of COVID-19 in the United States Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases The epidemiology of autoimmune diseases Biological properties of an influenza A virusspecific killer T cell clone. Inhibition of virus replication in vivo and YAZDANPANAH AND REZAEI | 59 induction of delayed-type hypersensitivity reactions Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies Clinical features of patients infected with 2019 novel coronavirus in Wuhan Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China Hemophagocytic lymphohistiocytosis: review of etiologies and management Histiocytic disorders: recent insights into pathophysiology and practical guidelines Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review SARS-CoV-2 infection in children Multisystem inflammatory syndrome in children related to COVID-19: a New York city experience Multisystem inflammatory syndrome in U.S. children and adolescents An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Hyperinflammatory shock in children during COVID-19 pandemic Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study Into the eye of the cytokine storm COVID-19: infection or autoimmunity Autoimmune haemolytic anaemia associated with COVID-19 infection Guillain-Barré syndrome associated with SARS-CoV-2 Immune thrombocytopenic purpura in a patient with COVID-19 Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology Guillain-Barré syndrome related to COVID-19 infection Guillain-Barré syndrome in a COVID-19 patient: a case report and review of management strategies Guillain-Barre syndrome and COVID-19: a case report Miller-Fisher syndrome after SARS-CoV-2 infection Miller Fisher syndrome and COVID-19: is there a link? Miller Fisher syndrome and polyneuritis cranialis in COVID-19 Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans Viral-associated immune thrombocytopenic purpura Clinical characteristics of coronavirus disease 2019 in China Immune thrombocytopenic purpura after COVID-19 infection A rare case of immune thrombocytopenic purpura, secondary to COVID-19 Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: report of a case Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis Thrombocytopenia in patients with severe acute respiratory syndrome Severe autoimmune hemolytic anemia in COVID-19 infection, safely treated with steroids Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia Insights from a prospective follow-up of thyroid function and autoimmunity among COVID-19 survivors Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19 COVID-19: a cause of recurrent Graves' hyperthyroidism? New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases Guillain-Barré syndrome related to SARS-CoV-2 infection A case series of Guillain-Barré syndrome following Covid-19 infection in New York Guillain-Barré syndrome associated with COVID-19 Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions COVID-19 provoking Guillain-Barré syndrome: the Bergamo case series Incidence, clinical, risk factors and outcomes of Guillain-Barré in covid-19 COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: the experience of Liguria region in Italy Neurological manifestations of COVID-19: a series of seven cases Immune-mediated neurological syndromes in SARS-CoV-2-infected patients Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome Clinical description of the broad range of neurological presentations of COVID-19: a retrospective case series SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: a case series Neurologic manifestations associated with COVID-19: a multicentre registry Covid-19 associated Guillain-Barre Syndrome: contrasting tale of four patients from a tertiary care centre in India The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: a case report and review of the literature Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review COVID-19-associated immune thrombocytopenia SARS-CoV-2 Infection Inducing immune thrombocytopenic purpura: case series Thrombocytopenia in the course of COVID-19 infection Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series Coronavirus disease associated immune thrombocytopenia: causation or correlation? Immune thrombocytopenic purpura-different presentations in two COVID-19 patients A rare case of immune thrombocytopenic purpura, secondary to COVID-19 Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case series SARS-CoV-2-associated cold agglutinin disease: a report of two cases Cold agglutinin syndrome as a complication of COVID-19 in two cases Autoimmune haemolytic anaemia associated with COVID-19 infection SARS-CoV-2-related multisystem inflammatory syndrome in children: a case series Multisystem inflammatory syndrome in children in New York state COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar The challenging diagnosis of pediatric multisystem inflammatory syndrome associated with Sars-Cov-2 infection-two case reports and literature review Multisystem inflammatory syndrome in children (MIS-C)-a case series in December 2020 in Vienna Pediatric inflammatory multisystem syndrome associated with COVID-19: a report of 10 cases in a Peruvian hospital Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK Tertiary Paediatric Hospital Successful treatment of pediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) with split doses of immunoglobulin G and estimation of PIMS-TS incidence in a county district in southern Germany Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves' disease after COVID-19 Thyroid function analysis in 50 patients with COVID-19: a retrospective study High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: High levels of anti-SSA/Ro antibodies in COVID-19 Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Kawasaki disease and multisystem inflammatory syndrome in children with COVID-19 How to cite this article Autoimmune complications of COVID-19